Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
October 23, 2026 1.605
October 22, 2026 1.590
October 21, 2026 1.574
October 20, 2026 1.567
October 19, 2026 1.415
October 16, 2026 1.361
October 15, 2026 1.464
October 14, 2026 1.476
October 13, 2026 1.521
October 12, 2026 1.62
October 09, 2026 1.658
October 08, 2026 1.62
October 07, 2026 1.635
October 06, 2026 1.742
October 05, 2026 1.848
October 02, 2026 1.764
October 01, 2026 1.749
September 30, 2026 1.802
September 29, 2026 1.810
September 28, 2026 1.810
September 25, 2026 1.787
September 24, 2026 1.772
September 23, 2026 1.848
September 22, 2026 1.962
September 21, 2026 1.924
Date Value
September 18, 2026 1.924
September 17, 2026 1.917
September 16, 2026 1.856
September 15, 2026 1.787
September 14, 2026 1.780
September 11, 2026 1.757
September 10, 2026 1.772
September 09, 2026 1.856
September 08, 2026 1.901
September 04, 2026 1.886
September 03, 2026 1.840
September 02, 2026 1.863
September 01, 2026 1.848
August 31, 2026 1.818
August 28, 2026 1.848
August 27, 2026 1.932
August 26, 2026 1.955
August 25, 2026 1.939
August 24, 2026 1.856
August 21, 2026 1.772
August 20, 2026 1.863
August 19, 2026 2.015
August 18, 2026 1.947
August 17, 2026 1.993
August 14, 2026 1.955

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

PS Ratio 38.90
Price 2.11
Earnings Yield -49.91%
Market Cap 246.22M